Evidence map›Paper›PMID 39199143›Full record

ReviewAntioxidants (Basel, Switzerland)2024

The Multifaceted Role of Alpha-Lipoic Acid in Cancer Prevention, Occurrence, and Treatment.

Shuai Yan, Jiajie Lu, Bingqing Chen, Liuxia Yuan, Lin Chen, Linglin Ju, Weihua Cai, Jinzhu Wu

Registry-linked trialAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07736495 (Evaluation of the Protective Effect of Alpha-Lipoic Acid Against 5-Fluorouracil-Induced Oral Mucositis in Colorectal Cancer Patients), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07736495 phase2 / phase3recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of the Protective Effect of Alpha-Lipoic Acid Against 5-Fluorouracil-Induced Oral Mucositis in Colorectal Cancer Patients

TypeinterventionalSponsorAin Shams UniversityRan2026 to 2026Enrolled50ConditionsColorectal CancerArmsalpha lipoic acid 600 mg twice daily, Placebo Tablet
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuai YanMedical School, Nantong University, Nantong 226300, China.ORCID 0009-0000-3691-2077
Jiajie LuMedical School, Nantong University, Nantong 226300, China.
Bingqing ChenMedical School, Nantong University, Nantong 226300, China.
Liuxia YuanInstitute of Liver Diseases, Affiliated Nantong Hospital 3 of Nantong University, Nantong 226300, China.
Lin ChenInstitute of Liver Diseases, Affiliated Nantong Hospital 3 of Nantong University, Nantong 226300, China.
Linglin JuInstitute of Liver Diseases, Affiliated Nantong Hospital 3 of Nantong University, Nantong 226300, China.
Weihua CaiDepartment of Hepatobiliary Surgery, Affiliated Nantong Hospital 3 of Nantong University, Nantong 226300, China.
Jinzhu WuMedical School, Nantong University, Nantong 226300, China.ORCID 0000-0002-7295-2030

Funding

Nantong Municipal Health Commission MSZ2022036Postgraduate Research & Practice Innovation Program of Jiangsu Province SJCX24_2067
6 · The paper itself

Abstract

Alpha-lipoic acid (ALA) is a naturally occurring compound synthesized by mitochondria and widely distributed in both animal and plant tissues. It primarily influences cellular metabolism and oxidative stress networks through its antioxidant properties and is an important drug for treating metabolic diseases associated with oxidative damage. Nevertheless, research indicates that the mechanism by which ALA affects cancer cells is distinct from that observed in normal cells, exhibiting pro-oxidative properties. Therefore, this review aims to describe the main chemical and biological functions of ALA in the cancer environment, including its mechanisms and effects in tumor prevention and anticancer activity, as well as its role as an adjunctive drug in cancer therapy. We specifically focus on the interactions between ALA and various carcinogenic and anti-carcinogenic pathways and discuss ALA's pro-oxidative capabilities in the unique redox environment of cancer cells. Additionally, we elaborate on ALA's roles in nanomedicine, hypoxia-inducible factors, and cancer stem cell research, proposing hypotheses and potential explanations for currently unresolved issues.

Indexed as

alpha-lipoic acidantioxidantscancernanomedicineoxidative stressreactive oxygen species

Identifiers

PMID39199143
PMCPMC11351715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.